|
1
|
Gibofsky A: Overview of epidemiology,
pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag
Care. 18:S295–S302. 2012.PubMed/NCBI
|
|
2
|
Semerano L, Minichiello E, Bessis N and
Boissier MC: Novel immunotherapeutic avenues for rheumatoid
arthritis. Trends Mol Med. 22:214–229. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Müller-Ladner U, Pap T, Gay RE, Neidhart M
and Gay S: Mechanisms of disease: The molecular and cellular basis
of joint destruction in rheumatoid arthritis. Nat Clin Pract
Rheumatol. 1:102–110. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Firestein GS: Evolving concepts of
rheumatoid arthritis. Nature. 423:356–361. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartok B and Firestein GS: Fibroblast-like
synoviocytes: Key effector cells in rheumatoid arthritis. Immunol
Rev. 233:233–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huber LC, Distler O, Tarner I, Gay RE, Gay
S and Pap T: Synovial fibroblasts: Key players in rheumatoid
arthritis. Rheumatology (Oxford). 45:669–675. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirano T: Interleukin 6 and its receptor:
Ten years later. Int Rev Immunol. 16:249–284. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Okamoto H, Yamamura M, Morita Y, Harada S,
Makino H and Ota Z: The synovial expression and serum levels of
interleukin-6, interleukin-11, leukemia inhibitory factor, and
oncostatin M in rheumatoid arthritis. Arthritis and Rheum.
40:1096–1105. 1997. View Article : Google Scholar
|
|
9
|
Hirano T, Matsuda T, Turner M, Miyasaka N,
Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, et al:
Excessive production of interleukin 6/B cell stimulatory factor-2
in rheumatoid arthritis. Eur J Immunol. 18:1797–1801. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dasgupta B, Corkill M, Kirkham B, Gibson T
and Panayi G: Serial estimation of interleukin 6 as a measure of
systemic disease in rheumatoid arthritis. J Rheumatol. 19:22–25.
1992.PubMed/NCBI
|
|
11
|
Ishihara K and Hirano T: IL-6 in
autoimmune disease and chronic inflammatory proliferative disease.
Cytokine Growth Factor Rev. 13:357–368. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feldmann M, Brennan FM and Maini RN: Role
of cytokines in rheumatoid arthritis. Annu Rev Immunol. 14:397–440.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alonzi T, Fattori E, Lazzaro D, Costa P,
Probert L, Kollias G, De Benedetti F, Poli V and Ciliberto G:
Interleukin 6 is required for the development of collagen-induced
arthritis. J Exp Med. 187:461–468. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ohshima S, Saeki Y, Mima T, Sasai M,
Nishioka K, Nomura S, Kopf M, Katada Y, Tanaka T, Suemura M and
Kishimoto T: Interleukin 6 plays a key role in the development of
antigen-induced arthritis. Proc Natl Acad Sci USA. 95:8222–8226.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hirano T, Ishihara K and Hibi M: Roles of
STAT3 in mediating the cell growth, differentiation and survival
signals relayed through the IL-6 family of cytokine receptors.
Oncogene. 19:2548–2556. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kong X, Liu C, Zhang C, Zhao J, Wang J,
Wan H, Zhu H, Zhang P, Chen W, Xiao Y and Lin N: The suppressive
effects of Saposhnikovia divaricata (Fangfeng) chromone extract on
rheumatoid arthritis via inhibition of nuclear factor-κB and
mitogen activated proteinkinases activation on collagen-induced
arthritis model. J Ethnopharmacol. 148:842–850. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Andreas K, Lübke C, Häupl T, Dehne T,
Morawietz L, Ringe J, Kaps C and Sittinger M: Key regulatory
molecules of cartilage destruction in rheumatoid arthritis: An in
vitro study. Arthritis Res Ther. 10:R92008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ruan Z, Liu S, Zhou Y, Mi S, Liu G, Wu X,
Yao K, Assaad H, Deng Z, Hou Y, et al: Chlorogenic acid decreases
intestinal permeability and increases expression of intestinal
tight junction proteins in weaned rats challenged with LPS. PLoS
One. 9:e978152014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
dos Santos MD, Almeida MC, Lopes NP and de
Souza GE: Evaluation of the anti-inflammatory, analgesic and
antipyretic activities of the natural polyphenol chlorogenic acid.
Biol Pharm Bull. 29:2236–2240. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tatefuji T, Izumi N, Ohta T, Arai S, Ikeda
M and Kurimoto M: Isolation and identification of compounds from
Brazilian propolis which enhance macrophage spreading and mobility.
Biol Pharm Bull. 19:966–970. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Ma J, Dong L, Hou Y, Jia X, Niu X
and Fan Y: Effect of anatase TiO2 nanoparticles on the growth of
RSC-364 rat synovial cell. J Nanosci Nanotechnol. 13:3874–3879.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo HF, Liu SX, Zhang YJ, Liu QJ, Hao J
and Gao LX: High mobility group box 1 induces synoviocyte
proliferation in rheumatoid arthritis by activating the signal
transducer and activator transcription signal pathway. Clin Exp
Med. 11:65–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kwak SC, Lee C, Kim JY, Oh HM, So HS, Lee
MS, Rho MC and Oh J: Chlorogenic acid inhibits osteoclast
differentiation and bone resorption by down-regulation of receptor
activator of nuclear factor kappa-B ligand-induced nuclear factor
of activated T cells c1 expression. Biol Pharm Bull. 36:1779–1786.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fan L, Wang Q, Liu R, Zong M, He D, Zhang
H, Ding Y and Ma J: Citrullinated fibronectin inhibits apoptosis
and promotes the secretion of pro-inflammatory cytokines in
fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res
Ther. 14:R2662012. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li G, Liu D, Guo S, Sunagawa M, Hisamitsu
T and Liu Y: Anti-invasive effects of Celastrus Orbiculatus extract
on interleukin-1 beta and tumour necrosis factor-alpha
combination-stimulated fibroblast-like synoviocytes. BMC Complement
Altern Med. 14:622014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marinova-Mutafchieva L, Williams RO, Funa
K, Maini RN and Zvaifler NJ: Inflammation is preceded by tumor
necrosis factor-dependent infiltration of mesenchymal cells in
experimental arthritis. Arthritis and Rheum. 46:507–513. 2002.
View Article : Google Scholar
|
|
27
|
Nakajima T, Aono H, Hasunuma T, Yamamoto
K, Shirai T, Hirohata K and Nishioka K: Apoptosis and functional
Fas antigen in rheumatoid arthritis synoviocytes. Arthritis and
Rheum. 38:485–491. 1995. View Article : Google Scholar
|
|
28
|
Liu YJ, Zhou CY, Qiu CH, Lu XM and Wang
YT: Chlorogenic acid induced apoptosis and inhibition of
proliferation in human acute promyelocytic leukemia HL60 cells. Mol
Med Rep. 8:1106–1110. 2013.PubMed/NCBI
|
|
29
|
Wu C, Luan H, Zhang X, Wang S, Zhang X,
Sun X and Guo P: Chlorogenic acid protects against atherosclerosis
in ApoE-/- mice and promotes cholesterol efflux from RAW264.7
macrophages. PLoS One. 9:e954522014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo YJ, Luo T, Wu F, Mei YW, Peng J, Liu
H, Li HR, Zhang SL, Dong JH, Fang Y and Zhao L: Involvement of TLR2
and TLR9 in the anti-inflammatory effects of chlorogenic acid in
HSV-1-infected microglia. Life Sci. 127:12–18. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Migita K, Komori A, Torigoshi T, Maeda Y,
Izumi Y, Jiuchi Y, Miyashita T, Nakamura M, Motokawa S and
Ishibashi H: CP690,550 inhibits oncostatin M-induced JAK/STAT
signaling pathway in rheumatoid synoviocytes. Arthritis Res Ther.
13:R722011. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Borie DC, O'Shea JJ and Changelian PS:
JAK3 inhibition, a viable new modality of immunosuppression for
solid organ transplants. Trends Mol Med. 10:532–541. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
